Idt Australia Ltd has released a press release.
Generics Sales Update
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from IDT Australia
- Completion of Initial CMAX Transaction
- Mayne Pharma Announces U.S. Launch of IDTs Temozolomide
- IDT: 1st generic proprietary prod shipped to US, temozolomide
- IDT Divests CMAX Clinical Trial Business to Irom Group
- Trading halt
Later from IDT Australia
- Appendix 3Z
- FDA review clears Pindolol for US launch
- US launch of Pindolol
- Corporate Governance Statement
- Director Retirement - Graeme Blackman
Follow IDT Australia into a list and get an email when it puts out news.
Follow IDT Australia